Latest filing published 03 Mar 2017 for FIVE PRIME THERAPEUTICS INC, €801k.
Insider track record
Robert Steven Sikorski: trading record in brief
This profile gathers the share dealings of Robert Steven Sikorski in Five Prime Therapeutics Inc. Between 1 June 2016 and 1 March 2017, the trades on record add up to 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 3 March 2017 with a share grant (€801k) in Five Prime Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Steven Sikorski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,899 shares@ US$44.7750.6% of flowCommon StockSEC:0001209191-17-017134:0
- 5,625 shares0Common StockSEC:0001209191-17-009291:0
- 14,531 shares0Common StockSEC:0001209191-17-009291:1
- 2,115 shares@ US$48.606.2% of flowCommon StockSEC:0001209191-17-001847:0
- 17,140 shares@ US$44.7443.2% of flowCommon StockSEC:0001209191-16-139563:0
- 10,000 shares0Common StockSEC:0001209191-16-139037:0
- 10,000 shares0Common StockSEC:0001209191-16-124855:0
7 of 7 declarations
